Napredna pretraga

Pregled bibliografske jedinice broj: 734743

Liječenje fistulirajućeg oblika Crohnove bolesti


Tonkić, Ante; Borzan, Vladimir
Liječenje fistulirajućeg oblika Crohnove bolesti // Acta medica Croatica. Supplement, 67 (2013), 191-194 (podatak o recenziji nije dostupan, pregledni rad, stručni)


Naslov
Liječenje fistulirajućeg oblika Crohnove bolesti
(Treatment of fistulizing Crohn's disease)

Autori
Tonkić, Ante ; Borzan, Vladimir

Izvornik
Acta medica Croatica. Supplement (1331-1638) 67 (2013); 191-194

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, stručni

Ključne riječi
Fistula; Crohnova bolest
(Fistula; Crohn's disease)

Sažetak
The treatment of fistulating Crohn's disease should include a combined medical and surgical approach and should be defined on an individual basis. Asymptomatic enteroenteric fistulas usually require no treatment, but internal fistulas (gastrocolic, duodenocolic, enterovesical) that cause severe or persistent symptoms require surgical intervention. While low asymptomatic anal-introital fistula may not need surgical treatment, in case of a symptomatic enterovaginal fistula surgery is usually required. There are no controlled-randomized trials to assess the effect of medical treatment for non-perianal fistulating Crohn's disease. The incidence of perianal fistulae varies according to the location of the disease, with its occurrence varying between 21-23%. The diagnostic approach should include an examination under anesthesia, endoscopy, and either MRI or EUS before the treatment begins. Asymptomatic simple perianal fistulas require no treatment. The presence of a perianal abscess should be ascertained and if present should be drained urgently. In case of a complex perianal disease, seton placement should also be recommended. Antibiotics (metronidazole and ciprofloxacine) are useful for treating complex perianal disease, however, when discontinued, most of the fistulas relapse. The current consensus suggests that azathioprine/6-mercaptopurine is the first line medical therapy for complex perianal disease, which is always given in combination with surgical therapy (seton, fistulotomy/fistulectomy). Anti TNF-alpha agents (infliximab and adalimumab) should be used as a second choice medical treatment. In refractory and extensive complex perianal disease a diverting stoma or proctectomy should be performed.

Izvorni jezik
Hrvatski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove
KBC Split,
Medicinski fakultet, Split

Autor s matičnim brojem:
Ante Tonkić, (231526)